EGFR and non-small cell lung carcinoma: Upregulation of EGFR pathway signaling is a common event in several kinds of chronic diseases, especially in cancers such as non-small-cell lung cancer (NSCLC), metastatic colorectal cancer, and glioblastoma (36).